Alvogen Group With Five Nominations For The Annual Global Generics and Biosimilar Awards

Lotus Pharmaceutical Co., Ltd (“Lotus” or “the Company”, Taiwan OTC ticker: 1795) today announced, on behalf of the Alvogen Group, that the group has been nominated in five categories for the annual Global Generics and Biosimilar awards 2017, sponsored by the trade publication, Generics Bulletin. Nominations include: Company of The Year, Company of The Year EMEA, Innovation of The Year, Business Development of The Year, and Corporate Social Responsibility Initiative of The Year.

Read More

Highly experienced management team with a proven track record of achieving high growth and profitability.


News alert

Enter your email to sign up for news alerts